Stay updated on Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial page.

Latest updates to the Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedFooter now shows Revision: v3.3.3; the HHS Vulnerability Disclosure and the previous Revision: v3.3.2 label were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2 with no visible content or layout changes; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision: v3.3.1 added and v3.2.0 removed are administrative version-tracking updates that do not affect core content or user experience. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check49 days agoChange DetectedRemoved the banner notice about funding-related site outages and potential data delays. It previously directed users to cc.nih.gov for operating status and opm.gov for updates.SummaryDifference0.9%

- Check63 days agoChange DetectedThe homepage shows only minor visual refinements to header/footer and styling, with core content and search functionality unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check92 days agoChange Detected- Added a government funding notice about potential delays and operating status, and directing users to cc.nih.gov and opm.gov for details. - Updated version from v3.1.0 (deleted) to v3.2.0 (added).SummaryDifference15%

Stay in the know with updates to Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial page.